Cargando…
Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma
Autores principales: | Spanoudakis, E, Papoutselis, M, Terpos, E, Dimopoulos, M A, Tsatalas, C, Margaritis, D, Rahemtulla, A, Kotsianidis, I, Karadimitris, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148055/ https://www.ncbi.nlm.nih.gov/pubmed/27834938 http://dx.doi.org/10.1038/bcj.2016.108 |
Ejemplares similares
-
Immunoporosis: A New Role for Invariant Natural Killer T (NKT) Cells Through Overexpression of Nuclear Factor-κB Ligand (RANKL)
por: Tilkeridis, Konstantinos, et al.
Publicado: (2019) -
The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition
por: Spanoudakis, Emmanouil, et al.
Publicado: (2018) -
Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report
por: Anastasiadis, Athanasios, et al.
Publicado: (2009) -
Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
por: Karadimitris, Anastasios, et al.
Publicado: (2019) -
Comparison of Invariant NKT Cells with Conventional T Cells by Using Gene Set Enrichment Analysis (GSEA)
por: Oh, Sae Jin, et al.
Publicado: (2011)